SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION

The results of studies of the safety of a combined five-component pediatric vaccine to prevent diphtheria, pertussis, tetanus, polio, Haemophilus influenzae type b (DTaP-IPV//Hib) in children in the primary vaccination and for the first boosterisation are shown. On the introduction of 208 doses of 2...

Full description

Saved in:
Bibliographic Details
Main Authors: N. D. Chernova, I. A. Ivanova, G. M. Demchuk, Y. E. Cousina, O. B. Valetova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2012-08-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/318
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839587340836667392
author N. D. Chernova
I. A. Ivanova
G. M. Demchuk
Y. E. Cousina
O. B. Valetova
author_facet N. D. Chernova
I. A. Ivanova
G. M. Demchuk
Y. E. Cousina
O. B. Valetova
author_sort N. D. Chernova
collection DOAJ
description The results of studies of the safety of a combined five-component pediatric vaccine to prevent diphtheria, pertussis, tetanus, polio, Haemophilus influenzae type b (DTaP-IPV//Hib) in children in the primary vaccination and for the first boosterisation are shown. On the introduction of 208 doses of 264 (75.8%) there were no any local or general reactions registered. The registered local or general reactions occurred usually on the 1st day after vaccination and lasted for 1–2 days. Local reactions with a diameter ≥ 2 cm were reported in 2 cases (0.8%) and did not exceed the diameter of 2 cm. Increased body temperature ≥ 38,5°C was recorded in 3 cases (1.1%) and was not higher than 39,0°C. There have been fixed no cases of anaphylactic reactions, seizures, encephalitic reactions. Due to the high-profile security vaccine DTaP-IPV//Hib is suitable for wide application in outpatient conditions for the standard routine and catch-up vaccination of healthy children and children with underlying medical conditions.
format Article
id doaj-art-a4c823b8e15746a6ac1a84b1ce872ce2
institution Matheson Library
issn 1727-5776
2500-3089
language Russian
publishDate 2012-08-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-a4c823b8e15746a6ac1a84b1ce872ce22025-08-03T19:21:15ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892012-08-0194323510.15690/pf.v9i4.387318SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATIONN. D. Chernova0I. A. Ivanova1G. M. Demchuk2Y. E. Cousina3O. B. Valetova4FGBU «Children's Health Center» Office of the President of the Russian Federation, MoscowFGBU «Children's Health Center» Office of the President of the Russian Federation, MoscowFGBU «Children's Health Center» Office of the President of the Russian Federation, MoscowFGBU «Children's Health Center» Office of the President of the Russian Federation, MoscowFGBU «Children's Health Center» Office of the President of the Russian Federation, MoscowThe results of studies of the safety of a combined five-component pediatric vaccine to prevent diphtheria, pertussis, tetanus, polio, Haemophilus influenzae type b (DTaP-IPV//Hib) in children in the primary vaccination and for the first boosterisation are shown. On the introduction of 208 doses of 264 (75.8%) there were no any local or general reactions registered. The registered local or general reactions occurred usually on the 1st day after vaccination and lasted for 1–2 days. Local reactions with a diameter ≥ 2 cm were reported in 2 cases (0.8%) and did not exceed the diameter of 2 cm. Increased body temperature ≥ 38,5°C was recorded in 3 cases (1.1%) and was not higher than 39,0°C. There have been fixed no cases of anaphylactic reactions, seizures, encephalitic reactions. Due to the high-profile security vaccine DTaP-IPV//Hib is suitable for wide application in outpatient conditions for the standard routine and catch-up vaccination of healthy children and children with underlying medical conditions.https://www.pedpharma.ru/jour/article/view/318safetydtap-ipv//hibvaccinationevaccination
spellingShingle N. D. Chernova
I. A. Ivanova
G. M. Demchuk
Y. E. Cousina
O. B. Valetova
SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
Педиатрическая фармакология
safety
dtap-ipv//hib
vaccination
evaccination
title SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
title_full SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
title_fullStr SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
title_full_unstemmed SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
title_short SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
title_sort safety of pediatric combinated vaccine for diphtheria pertussis tetanus polio and haemophilus influenza type b in the primary immunization and first boosterisation
topic safety
dtap-ipv//hib
vaccination
evaccination
url https://www.pedpharma.ru/jour/article/view/318
work_keys_str_mv AT ndchernova safetyofpediatriccombinatedvaccinefordiphtheriapertussistetanuspolioandhaemophilusinfluenzatypebintheprimaryimmunizationandfirstboosterisation
AT iaivanova safetyofpediatriccombinatedvaccinefordiphtheriapertussistetanuspolioandhaemophilusinfluenzatypebintheprimaryimmunizationandfirstboosterisation
AT gmdemchuk safetyofpediatriccombinatedvaccinefordiphtheriapertussistetanuspolioandhaemophilusinfluenzatypebintheprimaryimmunizationandfirstboosterisation
AT yecousina safetyofpediatriccombinatedvaccinefordiphtheriapertussistetanuspolioandhaemophilusinfluenzatypebintheprimaryimmunizationandfirstboosterisation
AT obvaletova safetyofpediatriccombinatedvaccinefordiphtheriapertussistetanuspolioandhaemophilusinfluenzatypebintheprimaryimmunizationandfirstboosterisation